Thor Ameri Chalmer

5PUBLICATIONS
4CO-AUTHORS
Regenerative medicine (incl. stem cells)MigrationInfant and child healthDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 09, 2020
Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.

Mathias Due Buron, Thor Ameri Chalmer, Finn Sellebjerg

|Nov 16, 2019
Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosis.

Thor Ameri Chalmer, Mathias Buron, Zsolt Illes

|May 14, 2019
Predictors of treatment outcome in patients with paediatric onset multiple sclerosis.

Tine Iskov Kopp, Morten Blinkenberg, Thor Ameri Chalmer

|Mar 17, 2019
Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study.

Mathias Due Buron, Thor Ameri Chalmer, Finn Sellebjerg

|May 31, 2018
Early versus later treatment start in multiple sclerosis: a register-based cohort study.

T A Chalmer, L M Baggesen, M Nørgaard

Pageof 1